暂无分享,去创建一个
Franco Blanchini | Raffaele Bruno | Patrizio Colaneri | Alessandro Di Filippo | Giulia Giordano | Angela Di Matteo | Marta Colaneri | P. Colaneri | F. Blanchini | R. Bruno | A. Di Filippo | G. Giordano | A. Di Matteo | M. Colaneri | A. Matteo | A. Filippo
[1] Michael McAleer,et al. Risk Management of COVID-19 by Universities in China , 2020, Journal of Risk and Financial Management.
[2] Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China , 2020, Nature Medicine.
[3] Shaoqiang Li,et al. Development and clinical application of a rapid IgM‐IgG combined antibody test for SARS‐CoV‐2 infection diagnosis , 2020, Journal of medical virology.
[4] P. Klepac,et al. Early dynamics of transmission and control of COVID-19: a mathematical modelling study , 2020, The Lancet Infectious Diseases.
[5] L. Yang,et al. Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak , 2020, International Journal of Infectious Diseases.
[6] P. Klepac,et al. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts , 2020, The Lancet Global Health.
[7] Min Kang,et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients , 2020, The New England journal of medicine.
[8] Wu Zhong,et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro , 2020, Cell Research.
[9] Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19) , 2020, Frontiers in Immunology.
[10] W. O. Kermack,et al. A contribution to the mathematical theory of epidemics , 1927 .
[11] Francesco Casella. Can the COVID-19 epidemic be managed on the basis of daily data? , 2020, ArXiv.
[12] Yongli Cai,et al. A conceptual model for the coronavirus disease 2019 (COVID-19) outbreak in Wuhan, China with individual reaction and governmental action , 2020, International Journal of Infectious Diseases.
[13] M. E. Alexander,et al. Modelling strategies for controlling SARS outbreaks , 2004, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[14] Dan Xu,et al. Positive RT-PCR Test Results in Patients Recovered From COVID-19. , 2020, JAMA.
[15] Bo Diao,et al. Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19) , 2020, Frontiers in Immunology.
[16] Yan Bai,et al. Presumed Asymptomatic Carrier Transmission of COVID-19. , 2020, JAMA.
[17] Potential Therapeutic Agents for COVID-19 Based on the Analysis of Protease and RNA Polymerase Docking , 2020 .
[18] Yuyi Wang,et al. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures , 2020, Journal of medical virology.
[19] J. Hyman,et al. Short-term Forecasts of the COVID-19 Epidemic in Guangdong and Zhejiang, China: February 13–23, 2020 , 2020, Journal of clinical medicine.
[20] Victor M Corman,et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[21] K. Yuen,et al. Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.
[22] C. Furlanello,et al. Mitigation Measures for Pandemic Influenza in Italy: An Individual Based Model Considering Different Scenarios , 2008, PloS one.
[23] Frank Diederich,et al. Mathematical Epidemiology Of Infectious Diseases Model Building Analysis And Interpretation , 2016 .
[24] T. Velavan,et al. The COVID‐19 epidemic , 2020, Tropical medicine & international health : TM & IH.
[25] Herbert W. Hethcote,et al. The Mathematics of Infectious Diseases , 2000, SIAM Rev..
[26] D. Cummings,et al. Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions , 2020, medRxiv.
[27] A. J. Hall. Infectious diseases of humans: R. M. Anderson & R. M. May. Oxford etc.: Oxford University Press, 1991. viii + 757 pp. Price £50. ISBN 0-19-854599-1 , 1992 .
[28] Zunyou Wu,et al. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.
[29] F. Brauer,et al. Mathematical Models in Population Biology and Epidemiology , 2001 .
[30] Maria Elena Bottazzi,et al. The SARS-CoV-2 Vaccine Pipeline: an Overview , 2020, Current Tropical Medicine Reports.
[31] Yunpeng Ji,et al. Potential association between COVID-19 mortality and health-care resource availability , 2020, The Lancet Global Health.
[32] G. Remuzzi,et al. COVID-19 and Italy: what next? , 2020, The Lancet.
[33] C. Anastassopoulou,et al. Data-based analysis, modelling and forecasting of the COVID-19 outbreak , 2020, PloS one.
[34] Maimuna S. Majumder,et al. Estimation of MERS-Coronavirus Reproductive Number and Case Fatality Rate for the Spring 2014 Saudi Arabia Outbreak: Insights from Publicly Available Data , 2014, PLoS currents.
[35] Per Block,et al. Demographic science aids in understanding the spread and fatality rates of COVID-19 , 2020, Proceedings of the National Academy of Sciences.